Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

133%(4 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_4

50%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 4Post-market surveillance

2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (33.3%)

Phase 42 (66.7%)

Trials by Status

completed375%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_4

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

NCT00351611

completedphase_4

Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)

NCT01455428

completed

Clinical Study With Lyrica In Patients Suffering From Epilepsy

NCT00922987

terminatedphase_2

A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia

NCT00696787

Clinical Trials (4)

Showing 4 of 4 trials

NCT00351611Phase 4

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Completed

NCT01455428Phase 4

Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)

Completed

NCT00922987

Clinical Study With Lyrica In Patients Suffering From Epilepsy

Completed

NCT00696787Phase 2

A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia

Terminated

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4